Thadhani, Ravi, Hagmann, Henning, Schaarschmidt, Wiebke, Roth, Bernhard, Cingoez, Tuelay, Karunnanchi, S. Ananth, Wenger, Julia, Lucchesi, Kathryn J., Tamez, Hector, Lindner, Tom, Fridman, Alexander, Thome, Ulrich, Kribs, Angela, Danner, Marco, Hamacher, Stefanie ORCID: 0000-0003-2158-9101, Mallmann, Peter, Stepan, Holger and Benzing, Thomas (2016). Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. J. Am. Soc. Nephrol., 27 (3). S. 903 - 914. WASHINGTON: AMER SOC NEPHROLOGY. ISSN 1533-3450

Full text not available from this repository.

Abstract

Preeclampsia is a devastating complication of pregnancy. Soluble Fms-like tyrosine kinase-1 (sFlt-1) is an antiangiogenic protein believed to mediate the signs and symptoms of preeclampsia. We conducted an open pilot study to evaluate the safety and potential efficacy of therapeutic apheresis with a plasma specific dextran sulfate column to remove circulating sFlt-1 in 11 pregnant women (20-38 years of age) with very preterm preeclampsia (23-32 weeks of gestation, systolic BP >= 140 mmHg or diastolic BP >= 90 mmHg, new onset protein/creatinine ratio >0.30 g/g, and sFlt-1/placental growth factor ratio >85). We evaluated the extent of sFlt-1 removal, proteinuria reduction, pregnancy continuation, and neonatal and fetal safety of apheresis after one (n=6), two (n=4), or three (n=1) apheresis treatments. Mean sFlt-1 levels were reduced by 18% (range 7%-28%) with concomitant reductions of 44% in protein/creatinine ratios. Pregnancy continued for 8 days (range 2-11) and 15 days (range 11-21) in women treated once and multiple times, respectively, compared with 3 days (range 0-14) in untreated contemporaneous preeclampsia controls (n=22). Transient maternal BP reduction during apheresis was managed by withholding pre-apheresis antihypertensive therapy, saline prehydration, and reducing blood flow through the apheresis column. Compared with infants born prematurely to untreated women with and without preeclampsia (n=22 per group), no adverse effects of apheresis were observed. In conclusion, therapeutic apheresis reduced circulating sFlt-1 and proteinuria in women with very preterm preeclampsia and appeared to prolong pregnancy without major adverse maternal or fetal consequences. A controlled trial is warranted to confirm these findings.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Thadhani, RaviUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hagmann, HenningUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schaarschmidt, WiebkeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Roth, BernhardUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Cingoez, TuelayUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Karunnanchi, S. AnanthUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wenger, JuliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lucchesi, Kathryn J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Tamez, HectorUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lindner, TomUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fridman, AlexanderUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thome, UlrichUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kribs, AngelaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Danner, MarcoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hamacher, StefanieUNSPECIFIEDorcid.org/0000-0003-2158-9101UNSPECIFIED
Mallmann, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stepan, HolgerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Benzing, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-283907
DOI: 10.1681/ASN.2015020157
Journal or Publication Title: J. Am. Soc. Nephrol.
Volume: 27
Number: 3
Page Range: S. 903 - 914
Date: 2016
Publisher: AMER SOC NEPHROLOGY
Place of Publication: WASHINGTON
ISSN: 1533-3450
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ENDOTHELIAL GROWTH-FACTOR; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; DENSITY-LIPOPROTEIN APHERESIS; ANGIOGENIC FACTORS; EXTRACORPOREAL REMOVAL; FACTOR RECEPTOR-1; PREGNANCY; RISK; HYPERTENSION; MODELMultiple languages
Urology & NephrologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/28390

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item